X

Healthcare

Metropolis Healthcare Reports 26% Revenue Growth in Q3; Board Approves 3:1 Bonus Issue

India’s second-largest diagnostic chain saw net profit surge 63% on an adjusted basis as specialty testing and acquisition integrations drove…

Inventurus Knowledge Q3 FY26 Earnings Results

Executive Summary Inventurus Knowledge Solutions Ltd reported Q3FY26 revenues of ₹815 crore, up 24.05% YoY, with consolidated net profit increasing…

Rubicon Research Reports 52% Revenue Growth in Q3 FY26; Profit Nearly Doubles

Rubicon Research Limited (NSE: RUBICON) shares were trading higher following the release of its Q3 FY26 earnings, though stock price…

Aster DM Healthcare Q3 Revenue Rises 13% as Company Advances QCIL Merger Integration

Aster DM Healthcare Limited (NSE: ASTERDM) the healthcare provider reported consolidated revenue of ₹1,185.76 crore for the quarter ended December…

Glenmark Pharmaceuticals Q3 FY26 Revenue Rises 15.1% on Strong Domestic and North American Growth

Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) reported consolidated revenue of ₹39,006 million for the third quarter ended December 31, 2025, a…

Glenmark Rallies as Q3 Margins Expand, FDA Clears U.S. Facility

Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) The Mumbai-based pharmaceutical company posts strong domestic and international sales as it transitions toward an…

Rainbow Children’s Medicare’s Q3 FY26 Results Reflect Capacity Expansion and Operational Transition

In its Q3 FY2026 financial results, Rainbow Children’s Medicare Ltd (NSE: RAINBOW) delivered a measured performance that reflected both steady…

Piramal Pharma Ltd Q3 FY 2026 Financial Results: Navigating Cyclical Headwinds with Strategic Adjustments

Piramal Pharma Ltd (NSE: PPLPHARMA), a leading global pharmaceutical and life sciences company headquartered in Mumbai, reported its financial results…

Thyrocare posts strong Q3 profit growth on higher diagnostic volumes

Thyrocare Technologies Ltd. (THYROCARE.NS) on Wednesday reported higher revenue and profit for the third quarter of fiscal 2026, supported by…

Vimta Labs Q3 Revenue Rises 10%, Profit Flat Amid Margin Pressure

Vimta Labs Ltd. (NSE: VIMTALABS) on Wednesday reported a modest rise in quarterly revenue for the three months ended Dec.…